Brightmind.ai: Funding, Investors & Team (Sep 2026)
Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest breakthroughs in neurotechnology at-home. We leverage cutting edge research to develop drastically better solutions for the greatest challenges to brain health. AI powered, personalized Neurotech Our vision is that Brightmind.AI’s personalized brain stimulation solutions are available in homes worldwide, offering to address globally important challenges to brain health such as pain relief, preventing cognitive decline and treating depression. Our first Use Case – Migraine Current solutions fail to achieve satisfactory outcomes: about 25% of 80 million migraineurs in the US and Europe are dissatisfied with existing treatment options. Research indicates that the stimulation protocol we use reduces migraine attacks by over 50%, for up to 90% of migraineurs.
Brightmind.ai has raised $800k across 1 funding round on record, the most recent an undisclosed round of $800k announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Brightmind.ai Company Profile and Key Stats
Latest funding round on record: May 2024.
Brightmind.ai Funding Rounds
Brightmind.ai Founders and Leadership Team
Contact details for the Brightmind.ai team: 1 of 1 has an email address on file.
Start 14-day free trial →Brightmind.ai Funding Compared to Other Biotechnology Startups
Brightmind.ai's latest round of $800k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Brightmind.ai in Biotechnology and Vienna
Companies Similar to Brightmind.ai
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell…
VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments,…
aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision…
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious…
The patented technology developed by Lignovations allows for the creation of lignin particles in the…
Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal…
Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into…
Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Brightmind.ai Funding FAQs
What does Brightmind.ai do?
Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest breakthroughs in neurotechnology at-home. We leverage cutting edge research to develop drastically better solutions for the greatest challenges to brain health. AI powered, personalized Neurotech Our vision is that Brightmind.AI’s personalized brain stimulation solutions are available in homes worldwide, offering to address globally important challenges to brain health such as pain relief, preventing cognitive decline and treating depression. Our first Use Case – Migraine Current solutions fail to achieve satisfactory outcomes: about 25% of 80 million migraineurs in the US and Europe are dissatisfied with existing treatment options. Research indicates that the stimulation protocol we use reduces migraine attacks by over 50%, for up to 90% of migraineurs.
How much funding has Brightmind.ai raised?
Brightmind.ai has raised $800k across 1 round on record. The most recent is an undisclosed round of $800k announced in May 2024.
When did Brightmind.ai last raise funding?
Brightmind.ai's most recent funding round on record is an undisclosed round of $800k, announced in May 2024.
Who founded Brightmind.ai?
FundedIQ lists Tamara Gerbert (Founder) at Brightmind.ai.
Where is Brightmind.ai headquartered?
Brightmind.ai is based in Vienna, Wien, Austria.
How many employees does Brightmind.ai have?
Brightmind.ai is in the 11-50 employee band.
How does Brightmind.ai's funding compare to other Biotechnology startups?
Brightmind.ai's latest round of $800k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Brightmind.ai Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Brightmind.ai is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.